BRIEF-Trinity Biotech Awarded A Major Order For 9 Million Trinscreen HIV TestsDec 23 (Reuters) - Trinity Biotech PLC TRIB.O:
TRINITY BIOTECH AWARDED A MAJOR ORDER FOR 9 MILLION TRINSCREEN HIV TESTS
TRINITY BIOTECH PLC - Q3 REVENUES INCREASED BY 32% TO $14.3M FROM Q2
TRINITY BIOTECH PLC - PAUL MURPHY PROMOTED TO INTERIM CFO AT TRINITY BIOTECH
TRINITY BIOTECH PLC - EXPECTS INCREASE IN ADJUSTED EBITDA THROUGHOUT Q1 AND Q2 OF 2026
Source text: ID:nGNXbwdmFF
Further company coverage: TRIB.O
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments